Innovative Vaccine Platforms • Influenza Research • Biotechnology Solutions
Capricorn Technologies is an Austrian biotechnology company specializing in influenza virology, vaccine platform development, and advanced viral technologies for human and animal health.
Our proprietary technologies build on expertise in influenza reverse genetics, immunology, and vaccine development. We develop innovative vaccine platforms and offer specialized research tools, customized virology services, and process development capabilities to academic and industry partners.
We welcome collaborations with pharmaceutical companies, vaccine manufacturers, and research organizations to advance vaccine technologies toward clinical and commercial applications.
OUR TECHNOLOGIES & VACCINE PROGRAMS
UniFluVec – Patented Influenza-Based Vaccine Platform
UniFluVec is Capricorn’s proprietary influenza-based vaccine platform, protected by patents granted in multiple countries and complemented by proprietary know-how in vaccine manufacturing, stabilization, lyophilization, and formulation.
The platform offers three potential applications: a broadly protective influenza vaccine, a viral vector for delivering heterologous antigens, and an immune-enhancing component for combination with other vaccine antigens.
Supported by extensive preclinical research and early clinical evaluation, UniFluVec provides a foundation for further vaccine development and strategic partnerships.
VetFluVec – Veterinary Vaccine Applications
Capricorn explores veterinary applications of its influenza-based vaccine technology, including vaccine candidates for livestock diseases and influenza in animals such as horses and camels. Research focuses on cellular immune responses and the potential for broader protection.
AEX-1 — Cell Platform for Influenza Virus Production
AEX-1 is Capricorn’s Vero-derived cell platform under development for influenza virus production. It complements our vaccine technologies and creates opportunities for research, process development, and manufacturing partnerships.
RESEARCH TOOLS & SERVICES
We support academic research, pharmaceutical development, and preclinical studies with specialized influenza research tools and tailored virology services.
Our offering includes influenza A reporter viruses expressing green fluorescent protein (GFP) or luciferase, as well as custom reverse-genetics projects. We also provide expertise in virus concentration and purification, including tangential flow filtration and diafiltration, tailored to project requirements.
We work with research teams to define solutions suited to their scientific questions and project requirements.
SCIENCE & INTELLECTUAL PROPERTY
Explore the publications, development milestones, patent portfolio, and proprietary technology know-how supporting Capricorn’s vaccine programs and influenza production technologies, including UniFluVec and AEX-1.
PARTNERSHIPS & COMPANY UPDATES
Capricorn Technologies has been a member of the Rapid Response Partnership Vehicle (RRPV) Consortium since 2026. We are interested in scientific collaborations, co-development programs, and industry partnerships.